Background
Coadministration of various drugs together with antidepressants can induce different side-effects in depressed patients. The authors report the case of a middle-aged woman, suffering from recurrent unipolar mood disorder, who developed an acute cutaneous reaction after the concomitant use of venlafaxine 225 mg/day and a combination product of orphenadrine citrate 105 mg/day and paracetamol 1350 mg/day.
Materials and Methods
To address whether the occurrence of this cutaneous reaction was the result of a possible allergic reaction or a drugdrug interaction.
In an attempt to identify the origin of this adverse effect, skin prick tests were performed in the patient with orphenadrine citrate and paracetamol in multiple dilutions. Five non-depressed patients, without a medical history of atopy, to whom it was recently prescribed orphenadrine citrate and paracetamol, were evaluated and were used as controls.
Results
Skin tests to orphenadrine citrate and paracetamol were negative both for the patient under consideration, as well as for the members of the control group. In addition, none of the individuals studied developed any delayed skin test reactions.
Discussion
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